Investigation of three common centrifugation protocols for platelet-rich fibrin (PRF) as a bio-carrier for ampicillin/sulbactam: a prospective trial
Authors:
Open Access
- 21 August 2023
- journal article
- research article
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 27 (10) , 5991-5998
Abstract
Objectives: Different platelet-rich fibrin (PRF) protocols exist and are known to differ in resulting mechanical and bioactive properties. Centrifugation parameters may also influence drug release, in particular antibiotics, when using PRF as a bio-carrier. We thus evaluated three common protocols regarding effects on the bio-carrier properties. Materials and methods: In a prospective trial comprising 33 patients, we compared different protocols for PRF as a bio-carrier for ampicillin/sulbactam (SAM). Blood samples were taken shortly after a single dose of ampicillin/sulbactam (2 g/1 g) was administered to patients intravenously. PRF was obtained by centrifugation and three protocols were used: protocol A (1300 rpm, 8 min, RCF-max = 208 g), B (2300 rpm, 12 min, RCF-max = 652 g), and C (1500 rpm, 14 min, RCF-max = 276 g). The antibacterial activity of PRF was investigated against five oral species in vitro, based on agar diffusion methodology. Results: The study demonstrates that a single dose of SAM is sufficient to reach high concentrations in PRF in all protocols (150 µg/ml), which is comparable to the plasma SAM concentration. Antibacterial activity was inferred from the diameter of inhibition zones seen in agar diffusion tests using PRF discs. Protocol B resulted in the largest inhibition zones. One-way ANOVA revealed statistically improved results for protocol B for some bacteria. Conclusions: The study provides valuable data on PRF antibiotic enrichment, notably SAM. A single dose of SAM is sufficient to reach clinically relevant concentrations in PRF. Clinical relevance: These findings potentially extend the application of PRF, for example in patients with osteonecrosis of the jaw or in oral surgery (e.g., stick bone).Keywords
Funding Information
- Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg
- Universitätsklinikum Würzburg
This publication has 38 references indexed in Scilit:
- Antimicrobial properties of platelet-rich preparations. A systematic review of the current pre-clinical evidencePlatelets, 2016
- Advanced Platelet-Rich Fibrin: A New Concept for Cell-Based Tissue Engineering by Means of Inflammatory CellsJournal of Oral Implantology, 2014
- Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratoriesClinical Microbiology and Infection, 2014
- How to optimize the preparation of leukocyte- and platelet-rich fibrin (L-PRF, Choukroun's technique) clots and membranes: Introducing the PRF BoxOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2010
- Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part I: Technological concepts and evolutionOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2006
- Untersuchungen zum Ampicillin/Sulbactam-Spiegel im bestrahlten Unterkieferknochen bei Patienten mit oralen PlattenepithelkarzinomenMund-,Kiefer- und Gesichtschirurgie, 2005
- Pharmacokinetics of ampicillin, sulbactam and cefotiam in patients undergoing orthopedic surgeryInfection, 1997
- Concentrations of ampicillin and sulbactam in serum and in various compartments of the respiratory tract of patientsInfection, 1994
- Pharmacokinetics of ampicillin and sulbactam in patients undergoing heart surgeryAntimicrobial Agents and Chemotherapy, 1991
- Pharmacokinetics of Sulbactam/Ampicillin in Humans: A ReviewClinical Infectious Diseases, 1986